Jul 04, 2019
3:2
For every 2 shares held, investors received 3. The price per share adjusted from $24.03 to $16.02.
The split itself did not change the total investment value.
Beijing SL Pharmaceutical Co. Ltd. Class A (SZSE:002038) operates in the Biotechnology industry.
Beijing SL Pharmaceutical Co. Ltd. Class A company overviewBeijing SL Pharmaceutical Co. Ltd. Class A's most recent stock split was on July 4, 2019. It was a 3-for-2 forward split, so shareholders received 3 shares for every 2 they held.
Beijing SL Pharmaceutical Co. Ltd. Class A (SZSE:002038) has split its stock 7 times: a 6-for-5 split on April 19, 2005, a 3-for-2 split on April 18, 2007, a 2-for-1 split on May 9, 2008, a 3-for-2 split on April 27, 2011, a 6-for-5 split on May 28, 2013, a 3-for-2 split on July 15, 2015, and a 3-for-2 split on July 4, 2019.
Beijing SL Pharmaceutical Co. Ltd. Class A has split its stock 7 times. This history records 7 forward splits between April 19, 2005 and July 4, 2019.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Beijing SL Pharmaceutical Co. Ltd. Class A's 3-for-2 split on July 4, 2019, every 2 shares became 3 shares.
Beijing SL Pharmaceutical Co. Ltd. Class A has not announced a new split in our records. Its most recent split was on July 4, 2019, 7 years ago. Companies announce splits in advance, and any new SZSE:002038 split will appear on this page.
Already premium?